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ABSTRACT A study was carried out on 57 patients with chronic renal failure in a hospital in Kerman city, 
Islamic Republic of Iran. Blood samples were taken before and after haemodialysis to measure blood 
urea nitrogen and serum creatinine, triiodothyronine (T3) and thyroxine (T4) levels. Findings revealed 
that before dialysis T4 in 11 cases and T3 in 29 cases were lower than the normal range, but after 
haemodialysis only 3 cases for T4 and 15 cases for T3 were lower than normal levels. The remaining 
cases reverted to normal state. We suggest that a feedback relationship exists between the major end 
catabolic products (creatinine and blood urea nitrogen) and thyroid hormone serum levels. 
Les taux de créatinine, d'azote uréique sanguin et d’hormones thyroïdiennes avant et après une 
hémodialyse
RÉSUMÉ Une étude a été réalisée sur 57 patients atteints d’insuffisance rénale chronique dans un 
hôpital de la ville de Kerman (République islamique d’Iran). On a prélevé des échantillons sanguins 
avant et après une hémodialyse pour mesurer les taux d’azote uréique sanguin, de créatinine sérique, 
de triiodothyronine (T3) et de thyroxine (T4). Les résultats ont indiqué que la T4 et la T3 étaient infé-
rieures aux valeurs normales pour 11 cas et 29 cas respectivement avant la dialyse, et que 3 cas pour 
la T4 et 15 cas pour la T3 seulement avaient des valeurs inférieures à la normale après l’hémodialyse. 
Les autres cas sont revenus à un état normal. Ceci nous donne à penser qu’une relation de rétroaction 
existe entre les principaux produits cataboliques finals (créatinine et azote uréique sanguin) et le taux 
sérique d’hormones thyroïdiennes.  
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Introduction
Endocrine abnormalities in patients with 
chronic renal failure are well documented 
[1]. Previous studies using thyroid function 
test shows lower thyroid hormone concen-
trations in haemodialysed patients [1–6]. 
Studies have shown that patients with urae-
mia may manifest some varie-ties of hor-
monal abnormality, including decreased 
serum concentrations of thyroid and gonad-
al hormones and increased serum levels of 
growth hormone and prolactin [5–8]. Secre-
tion of thyroid hormones and their metabo-
lism in humans are controlled at 2 levels: 
the hypothalamic–pituitary–thyroid nega-
tive feedback axis controls thyroidal secre-
tion, while extra-thyroidal tissues regulate 
the production of triiodothyronine (T3) and 
are responsible for thyroid hormone degra-
dation [5–7]. The thyroid gland produces 
thyroxine (T4) but only 20% of the most 
metabolically active thyroid hormone T3 
and 5% to 8% of the calorigenically inactive 
reverse T3 (RT3) hormone and T4 in tissues 
such as liver, kidneys and muscles [8,9].
Haemodialysis employs the process of 
diffusion across a semi-permeable mem-
brane to remove excretion products and 
excess ﬂuids from the blood, while adding 
desirable components [2]. Regular periodic 
haemodialysis may reverse dynamic thyroid 
function. 
The aim of this study was to compare 
the serum levels of thyroid hormones T3 
and T4 with blood urea nitrogen (BUN) 
and creatinine serum levels in patients 
with chronic renal failure, before and after 
haemodialysis. 
Methods
The study took place at Shafa Hospital in 
Kerman city, Islamic Republic of Iran in 
February 2002. The initial study group was 
67 patients with chronic renal failure who 
had been receiving weekly haemodialysis 
for more than 1 year. 
A standard form was ﬁlled for each 
patient with age, sex, duration of dialysis, 
family history and signs of any other dis-
ease. Two blood samples was taken from 
each patient, 1 immediately before and 1 
immediately after haemodialysis. The mean 
time of dialysis was 3 hours.
Standard methods were used to measure 
serum levels of creatinine, BUN, T3 and T4 
by routine biochemical and radioimmuno-
assay tests (Embee Diagnostics, Delhi). The 
normal range for T3 levels in our laboratory 
was 80–200 ng/dL and for T4 levels was 
4.5–12.0 μg/dL
This study was planned to have 80% 
power to detect thyroid hormone serum 
levels at the 5% signiﬁcance level. Means 
and standard deviation (SD) were presented 
for comparing groups before and after 
haemodialysis. The data were analysed 
using Epi-Info, version 6. The relationship 
between creatinine or BUN and thyroid 
hormone levels was statistically analysed 
using analysis of variance and Mantel-
Haenszel and Fisher Exact tests; the level 
of signiﬁcance was P < 0.05.
Results
Of the 67 dialysis patients entered in the 
study, full data were obtained for 57 pa-
tients (31 males and 26 females). The mean 
serum BUN level was 102.8 mg/dL before 
and 31.4 mg/dL after haemodialysis (Table 
1). Mean serum creatinine levels were 11.3 
mg/dL and 4.7 mg/dL before and after 
haemodialysis respectively. Mean serum T3 
and T4 hormone levels were 78.0 ng/dL and 
6.2 μg/dL before and 102.5 ng/dL and 8.4 
μg/dL after haemodialysis respectively. 
Our ﬁndings showed that before dialysis 
T4 levels in 11 cases and T3 levels in 29 
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cases were lower than the normal range 
(Table 2). After haemodialysis, only 3 cases 
had T4 lower than the normal range and 15 
cases had below normal T3 serum levels. 
The remaining cases showed reversal of 
serum levels to normal ranges. 
Discussion
The aim of this study was to compare the se-
rum levels of thyroid hormones T3 and T4 
with BUN and creatinine levels in patients 
with chronic renal failure, before and after 
haemodialysis. Periodic blood dialysis was 
done in the Shafa Hospital centre by dialysis 
machine. Uraemia is based on recognition 
of a constellation of signs and symptoms 
with or without reduced urine output, but 
the serum levels of BUN and creatinine are 
always increased [7,8]. Our study showed 
the mean BUN level before and after 
haemodialysis was 102.8 mg/dL and 31.4 
mg/dL respectively, indicating that our di-
alysis machines were functioning properly. 
Injection of urine, urea or other retained 
toxic metabolites, and nephrectomy, would 
diminish catabolism and also the basal heat 
[6,10]. Elevation of serum urea nitrogen 
Table 1 Relation between blood urea nitrogen (BUN) and serum 
creatinine, triiodothyronine (T3) and thyroxine (T4) levels in 57 patients 
with chronic renal failure, before and after haemodialysis   
Variable  Before dialysis After dialysis Analysis of 
(normal range) Mean SD Mean SD variance
BUN (10–50 mg/dL) 102.8  49.0 31.4  27.0 P < 0.05
Creatinine (0.7–1.4 
 mg/dL) 11.3 4.2 4.7  2.7 P < 0.05
T3 (80–200 ng/dL) 78.0 26.5 102.5  42.0 P < 0.05
T4 (4.5–12.0 µg/dL) 6.2 2.1 8.4  2.4 P < 0.05
SD = standard deviation. 
Table 2 Serum levels of thyroxin (T4) and triiodothyronine (T3) in 57 
patients with chronic renal failure, before and after dialysis  
Variable  Before  After  Mantel–Haenszel test
(normal range) dialysis dialysis
  No.  No. 
T4   χ2 = 6.08, P = 0.047
 Low (< 4.5 µg/dL) 11 3 
 Normal (4.5–12.0 µg/dL) 44 51 
 High (> 12.0 µg/dL) 1 3 
 Total 56 57 
T3   χ2 = 8.22, P = 0.004
 Low (< 80 ng/dL)  29 15 
 Normal (80–200 ng/dL)  25 41 
 High (> 200 ng/dL) 0 0 
 Total 54 56 
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and creatinine occurs late in the course of 
renal failure. Dialysis usually returns body 
temperature to the normal range [10]. In our 
study, before haemodialysis, T3 and T4 se-
rum levels were 78.0 ng/dL and 6.2 μg/dL, 
whereas they increased to 102.5 ng/dL and 
8.5 μg/dL after haemodialysis, respectively. 
Increased serum levels of toxic compounds 
in our dialysis patients caused diminishing 
serum levels of thyroid hormones following 
damage to the thyroid gland. Low thyroid 
secretion can decrease protein catabolism 
and low BUN stimulates catabolism by 
secretion of thyroid hormones. 
The ﬁnding that the sera of patients with 
uraemia can exert toxic effects in a variety 
of biologic test systems has motivated 
a search to identify the responsible toxin. 
Kokot et al. made a case–control study 
on the long-term effect of erythropoietin 
therapy on plasma levels of thyrotropin and 
thyroxine hormone in haemodialized pa-
tients [1]. They showed that erythropoietin 
therapy cannot change plasma concentra-
tions of T3 hormone but is able to induce 
a signiﬁcant increase in plasma levels of 
T4 hormone [1]. In our study, 8 out of 11 
cases with low T4 hormone serum levels 
before dialysis had normal T4 levels after 
haemodialysis, suggesting that haemodi-
alysis activates secretion of thyroid gland 
and catabolism. Furthermore, 14 out of 29 
cases with low serum levels of T3 returned 
to normal levels after dialysis. A study of 9 
haemodialysis patients with iron overload, 
before and after iron depletion, showed that 
thyroid abnormalities improved in 8 cases 
after iron depletion [11]. 
We conclude that haemodialysis may 
have a positive feedback effect on thyroid 
gland secretions. The thyroid gland hor-
mones increase catabolic activities resulting 
an increase in creatinine and BUN levels, 
which in turn switch off the secretion of thy-
roid hormones by a feedback mechanism.
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